WHO ICTRP trial
A randomized phase IV clinical trial comparing Nadolol and Isosorbide…
ISRCTN26221020 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting
Key facts
| Trial ID | ISRCTN26221020 |
|---|---|
| Public title | A randomized phase IV clinical trial comparing Nadolol and Isosorbide Mononitrate (ISMN) with the combination of Endoscopic Banding Ligation plus Nadolol and ISMN in the prevention of variceal rebleeding |
| Scientific title | A randomized phase IV clinical trial comparing Nadolol and Isosorbide Mononitrate (ISMN) with the combination of Endoscopic Banding Ligation plus Nadolol and ISMN in the prevention of variceal rebleeding |
| Primary sponsor | Individual Sponsor (Spain) |
| Registry | International Standard Randomised Controlled Trial Number (ISRCTN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not Specified |
| Countries | Spain |
| Conditions | Variceal bleeding Circulatory System Variceal bleeding |
| Interventions | Control group: nadolol + isosorbide mononitrate for the prevention of rebleeding Experimental group: nadolol + isosorbide mononitrate + endoscopic banding ligation for the prevention of rebleeding. |
| Registration date | Mar 24, 2006 |
| Target size | 160 |
| Secondary IDs | LEB-VE2002 |
| Registry page | isrctn.com |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: